These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 31825392)
1. [Clinical significance and possibilities of therapy of post-stroke depression]. Trusova NA; Levin OS Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9. Vyp. 2):60-67. PubMed ID: 31825392 [TBL] [Abstract][Full Text] [Related]
2. Advances in antidepressants for treating post-stroke depression. Paolucci S Expert Opin Pharmacother; 2017 Jul; 18(10):1011-1017. PubMed ID: 28535081 [TBL] [Abstract][Full Text] [Related]
4. Is it safe to use antidepressants after a stroke? Rampello L; Battaglia G; Raffaele R; Vecchio I; Alvano A Expert Opin Drug Saf; 2005 Sep; 4(5):885-97. PubMed ID: 16111451 [TBL] [Abstract][Full Text] [Related]
5. Post-Stroke Depression: A Review. Robinson RG; Jorge RE Am J Psychiatry; 2016 Mar; 173(3):221-31. PubMed ID: 26684921 [TBL] [Abstract][Full Text] [Related]
6. [Stroke and depression]. Sivolap YP; Damulin IV Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):143-147. PubMed ID: 31626232 [TBL] [Abstract][Full Text] [Related]
7. Antidepressants for people with epilepsy and depression. Maguire MJ; Marson AG; Nevitt SJ Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531 [TBL] [Abstract][Full Text] [Related]
10. Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Part 2: Treatment alternatives. Turner-Stokes L; Hassan N Clin Rehabil; 2002 May; 16(3):248-60. PubMed ID: 12017512 [TBL] [Abstract][Full Text] [Related]
12. Role of functional pharmacological therapy in post-stroke depression: a narrative review. Corallo F; Scarfì C; Arcadi FA; Formica C; Di Cara M; Palmeri R; Romeo L; Lo Buono V; Bramanti P; Marino S; De Cola MC J Int Med Res; 2020 Oct; 48(10):300060520950557. PubMed ID: 33081542 [TBL] [Abstract][Full Text] [Related]
13. Heterocyclics and selective serotonin reuptake inhibitors in the treatment and prevention of poststroke depression. Bhogal SK; Teasell R; Foley N; Speechley M J Am Geriatr Soc; 2005 Jun; 53(6):1051-7. PubMed ID: 15935033 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological management of post-stroke depression: an update of the evidence and clinical guidance. Mortensen JK; Andersen G Expert Opin Pharmacother; 2021 Jun; 22(9):1157-1166. PubMed ID: 33530765 [No Abstract] [Full Text] [Related]
16. Post-stroke depression: Mechanisms and pharmacological treatment. Villa RF; Ferrari F; Moretti A Pharmacol Ther; 2018 Apr; 184():131-144. PubMed ID: 29128343 [TBL] [Abstract][Full Text] [Related]
17. A Chinese Classical Prescription Chaihu Shugan Powder in Treatment of Post-Stroke Depression: An Overview. Gao Z; Wang Y; Yu H Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676679 [TBL] [Abstract][Full Text] [Related]
18. Antidepressants for people with epilepsy and depression. Maguire MJ; Weston J; Singh J; Marson AG Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360 [TBL] [Abstract][Full Text] [Related]